Atlas Trials

Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors

Clinical trial NCT04301011 · TERMINATED

Trial details

NCT number
NCT04301011
Sponsor
Turnstone Biologics, Corp.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Solid TumorMicrosatellite Stable Colorectal CancerHPV Positive Oropharyngeal Squamous Cell CarcinomaCervical CancerMelanoma (Skin)Cutaneous Squamous Cell CarcinomaMesotheliomaRenal Cell CarcinomaOropharynx Cancer
Start date
2020-06-02
Primary completion
2023-01-23
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.